Medtronic Continued Selling Flawed Defibrillators

From Bloomberg:

Medtronic Inc. continued selling flawed cardiac defibrillators for two years after learning that some of them may suddenly quit working, according to company documents filed in a California lawsuit.
After Medtronic last year recalled the devices, 19,000 people had to have surgery for a replacement, said Medtronic spokesman Rob Clark. At least one of them died from post- surgical complications, according to the man’s widow. Defibrillator patients are vulnerable to potentially fatal heartbeat irregularities, which the $20,000 devices detect and correct using electrical shocks.
“Medtronic has been taking products they know are not quite right and putting them into people rather than take the loss,” said Hunter Shkolnik, a New York lawyer, who said in a Feb. 13 interview that he represents more than 200 people whose Medtronic devices were recalled. “If you know there’s a problem with a component, you don’t put it out and sell it to people.”
Medtronic, the leader in the $10 billion-a-year market for heart rhythm devices, told 87,000 patients in February 2005 that the defibrillators implanted in their chests might fail. According to company documents filed in federal court in San Jose, California, the Minneapolis-based company had discovered the flaw in January 2003 and started producing a redesigned product one year later.

Posted by on February 16th, 2006 at 2:02 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.